🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy of Sirolimus (Rapamun...
Status
Unknown
Location
Detroit Medical Center, Harper University Hospital
Start Date
2004-01
Trial ID
NCT00252655
Treatments Being Tested
The primary objective of this study is to compare the therapeutic response ...
Status
Terminated
Location
Multiple Locations
Start Date
2003-12
Trial ID
NCT00076206
The aim of this study is to identify the optimal dose for EP0062 as monothe...
Status
Recruiting
Location
Yale School of Medicine
Start Date
2023-01-11
Trial ID
NCT05573126
Treatments Being Tested
Background: Hepatitis C recurrence, which invariably occurs in viremic liv...
Status
Completed
Location
Department of HPB Surgery and Transplant, Hospital Vall d´Hebron
Start Date
2012-10
Trial ID
NCT01707849
This study seeks to examine treatment therapy that will reduced regimen-rel...
Status
Active Not Recruiting
Location
St. Jude Children's Research Hospital
Start Date
2016-07-14
Trial ID
NCT02790515
Any time the words "you," "your," "I," or "me" appear, it is meant to apply...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2015-07-30
Trial ID
NCT02423915
This randomized phase II trial studies how well temsirolimus with or withou...
Status
Completed
Location
Providence Saint Joseph Medical Center/Disney Family Cancer Center
Start Date
2008-09
Trial ID
NCT00729586
Treatments Being Tested
This phase I trial studies the side effects and best dose of cetuximab when...
Status
Completed
Location
Fox Chase Cancer Center
Start Date
2008-11
Trial ID
NCT01637194
Treatments Being Tested
A Phase 2 multi-center, open-label, single arm study of nab-sirolimus in pa...
Status
Completed
Location
Hoag Memorial Hospital Presbyterian
Start Date
2023-10-20
Trial ID
NCT05997056
Treatments Being Tested
Anti-rejection medicines, also known as immunosuppressive drugs, are prescr...
Status
Completed
Location
Duke University Health System
Start Date
2018-07-30
Trial ID
NCT03504241